Each to their own.
The announcement yesterday was good news and it gave the company an opportunity to update the status and strategy moving forward. To me this was a "dry run" for the release of the SS and the firming of offtake agreements (from LOI's to Binding agreements).
It also enabled the company to spell out its strategy for the future- moving quickly and inexpensively from the DFS to supply of DOS ore. The report confirmed the thoughts of many in regard to the very high quality product, which is in much demand in a market where supply is dwindling. To me it is very clear that this is a medium term investment and the price will vary over the coming weeks.
Well done to those that sold and got back in ... risky business because there will be a time when that decrease will not happen and you will pay a premium to get back on board, or miss out.
My strategy is to reassess when we are producing and exporting ... the plans should be firm at that stage for the best utilisation for maximum benefits of the resources.
GLTAH
- Forums
- ASX - By Stock
- ADN
- General comments/chat
General comments/chat, page-2488
-
- There are more pages in this discussion • 41,857 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADN (ASX) to my watchlist
|
|||||
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.87M |
Open | High | Low | Value | Volume |
1.7¢ | 1.7¢ | 1.6¢ | $2.139K | 129.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 1009118 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 2695345 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 1009118 | 0.016 |
31 | 9717582 | 0.015 |
19 | 6047321 | 0.014 |
7 | 1955054 | 0.013 |
8 | 4499414 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 2695345 | 5 |
0.018 | 2423498 | 9 |
0.019 | 1116544 | 7 |
0.020 | 3506697 | 15 |
0.021 | 1769124 | 11 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
ADN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online